The effect of repeated stimulation on both the interferon and antibody systems and on reticuloendothelial activity was studied by injection of endotoxin 2 days before injection of (poly rI) :(poly rC). A single injection of endotoxin or (poly rI) (poly rC) increased or decreased the response in each system depending on the time of administration. If the injection of (poly rI): (poly rC) was preceded by an injection of endotoxin 2 days before, its activity was markedly reduced in all of the three systems studied. Although different doses of endotoxin were required to induce a state of hyporeactivity or tolerance to the effects of (poly rI): (poly rC) in either system, it is possible that a common mechanism underlies the hyporeactivity in all systems.
Polycytidylic acid/polyinosinic acid [(poly rI): (poly rC)], endotoxin, and other natural and synthetic polyanions have been reported to initiate interferon production (as reviewed in 6) and to stimulate reticuloendothelial activity (2, 9, 10, 11, 14, 17, 18 In addition, hyporeactivity or tolerance to repeated stimulation has been shown in the interferon production system, as preinjection of (poly rI): (poly rC) or bacterial endotoxin decreased the interferon response to a second injection of (poly rI) : (poly rC) (12, 23) .
Tolerance or hyporeactivity has never been demonstrated with the stimulatory effects of endotoxin or (poly rI): (poly rC) on reticuloendothelial activity or antibody production. Therefore, studies were undertaken to determine whether hyporeactivity occurred to the effects of (poly rI): (poly rC) on these two systems and whether this hyporeactivity was related to that seen in interferon production. Salmonella enteritidis endotoxin (ESE) was injected intravenously into mice 2 days before an intravenous injection of (poly rI) :(poly rC), an optimal time for production of hyporeactivity in the interferon system (23) . (Poly rI): (poly rC) itself was given at the time of maximum effect in the particular system involved. The effects on the reticuloendothelial system were studied by the clearance of intravenously injected carbon, on the interferon system by assay of serum interferon production, and on antibody production by assaying the number of spleen cells producing antibodies hemolytic for sheep red blood cells (SRBC).
MATERIALS AND METHODS
Animals. Swiss-Webster albino mice, obtained from Simonson Labs, Inc., Gilroy, Calif., were used in this study. They were housed in an air-conditioned room at 20 C and given food and water ad lib. All experiments were done with 6-to 7-week-old mice.
Material used. ESE was purchased from Difco Laboratories, Detroit, Mich., and was prepared in a stock solution of 1 mg/ml in normal saline and stored at 4 C.
Polyriboinosinic and polyribocytidylic acids were purchased from P-L Biochemicals, Inc., Milwaukee, Wis., and the (poly rI): (poly rC) homopolymer pair was prepared and characterized as previously described (8) .
The carbon suspension was Pelikan C-11/1431A kindly supplied by J. S. Remington.
SRBC were obtained as defibrinated sheep blood purchased from Bennett's Ranch, Napa, Calif.
Agarose was obtained from Van Interferon production. Interferon titers were measured in mouse serum with a plaque reduction assay on mouse L-cell monolayers employing bovine vesicular stomatitis virus (VSV), Indiana strain, as a challenge virus (15) . The interferon titer corresponded to the reciprocal of the highest dilution of the sample which reduced virus plaque formation by 50%.
Reticuloendothelial activity. Reticuloendothelial activity was measured by the rate of clearance of intravenously injected carbon from the circulation by the method of Biozzi, Benacerraf, and Halpern (1). Briefly, a suspension of carbon particles at a concentration of 5 mg/ml in saline was injected intravenously into the lateral tail vein of mice in an amount sufficient to equal a dosage of 100 mg/kg. The mice were bled at appropriate intervals from alternate retro-orbital venous plexuses by using heparinized 50-pliter micropipettes. This quantity of blood was immediately lysed into 1 antibody-producing spleen cells 6 days after antigen administration. When injected on the same day as the antigen (within 30 min of antigen injection), it caused no significant change, and, when injected 2 days after antigen administration, it depressed antibody production to 36% of the control value (P < 0.005).
A similar biphasic response was observed with injection of 50 Mug of ESE at various days before antigen administration (Fig. 1) . When administered 4 days before the antigen, ESE did not significantly alter the number of antibody-producing cells. If administered 2 days before antigen, ESE depressed antibody production to 71% of the control level (P < 0.05), but, when administered simultaneously with the antigen, it enhanced antibody response to 239% of the control value (P < 0.005).
When (poly rI): (poly rC) was injected 2 days before the antigen and 50 Mug of ESE was injected Fig. 2; reference 14) . These data have been replotted and added to Fig. 2 for direct comparison with our data obtained with (poly rI): (poly rC).
Administration of 50 ,ug of ESE 72 hr before the assay markedly enhanced carbon clearance as previously reported by MacGregor et al. (14) . Doses of 5 and 0.5 ,ug, however, showed no significant enhancement (Table 3) . Combined administration of 5 Ag of ESE at 72 hr and (poly rI) :(poly rC) at 20 hr before the assay demonstrated hyporeactivity in that the rate of clearance was increased from 0.038 ,ug per ml per min for (poly rI) (poly rC) alone to above control level (0.080 ,ug per ml per min) for combined administration (P < 0.005; Table 3 ). A 0.5-,ug amount of ESE caused partial hyporeactivity, returning the clearance rate about halfway back to the control level (Table 3 Fig. 2) , and increase interferon production (as reviewed in 6). (Poly rI): (poly rC) and other synthetic polyanions have been shown to be effective against a variety of acute viral infections in experimental models, to block growth of a variety of malignant tumors, and to protect mice from lethal infections with bacteria, fungi, or protozoa, as reviewed or discussed previously (7, 8) . Although interferon has been shown to play the critical role in the effect of (poly rI): (poly rC) in certain viral infections (reference 8 and others discussed therein), its role in nonviral infections and malignancies has yet to be defined. Other mechanisms such as reticuloendothelial activity, humoral antibody, and cellular immunity may mediate the protective effect of (poly rI) (poly rC) against nonviral challenges. The possibility of common control mechanisms underlying these different effects warranted further study.
Both endotoxin (14) and (poly rI): (poly rC) (Fig. 2) caused an initial suppression of the carbon clearance followed by an increase of the clearance rate. Endotoxin and (poly rI) : (poly rC) share other similarities, as both are embryotoxic, pyrogenic, stimulate interferon production, exert tumor necrotic effects, and have an adjuvant effect on antibody production (as reviewed in 6). Both (poly rI) (poly rC) and endotoxin also exert a biphasic effect on antibody production (Fig. 1 ). In the case of interferon production, it was, of course, impossible to demonstrate such a biphasic response since the negative response would have been measured as zero. This biphasic suggest that common mechanisms may be operating in all three cases, the nature of which remains to be established.
